U.S. Pharmacovigilance Market Size & Outlook, 2026-2033

Name: U.S. Pharmacovigilance Market Size & Outlook
Creator: Grand View Research
License: https://www.grandviewresearch.com/horizon/info/terms-of-use

The pharmacovigilance market in the United States is expected to reach a projected revenue of US$ 2,981.3 million by 2033. A compound annual growth rate of 3.4% is expected of the United States pharmacovigilance market from 2026 to 2033.

U.S. pharmacovigilance product life cycle outlook (Revenue, USD million, 2021-2033)
- Pre Clinical
- Phase I
- Phase II
- Phase III
- Phase IV
U.S. pharmacovigilance service provider outlook (Revenue, USD million, 2021-2033)
- In House
- Contract outsourcing
U.S. pharmacovigilance type outlook (Revenue, USD million, 2021-2033)
- Spontaneous reporting
- Intensified ADR Reporting
- Targeted Spontaneous Reporting
- Cohort Event Monitoring
- EHR Mining
U.S. pharmacovigilance end use outlook (Revenue, USD million, 2021-2033)
- Pharmaceuticals
- Biotechnology Companies
- Medical Device Manufacturers
- Others
U.S. pharmacovigilance therapeutic area outlook (Revenue, USD million, 2021-2033)
- Oncology
- Neurology
- Cardiology
- Respiratory Systems
- Others
U.S. pharmacovigilance process flow outlook (Revenue, USD million, 2021-2033)
- Case Data Management
  - Case Logging
  - Case Data Analysis
  - Medical Reviewing & Reporting
- Signal Detection
  - Adverse Event Logging
  - Adverse Event Analysis
  - Adverse Event Review & Reporting
- Risk Management System
  - Risk Evaluation System
  - Risk Mitigation System

U.S. Pharmacovigilance Market Size & Outlook, 2026-2033

Sign up - it's easy, and free!